These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25259711)

  • 1. Galectin expression profiling identifies galectin-1 and Galectin-9Δ5 as prognostic factors in stage I/II non-small cell lung cancer.
    Schulkens IA; Heusschen R; van den Boogaart V; van Suylen RJ; Dingemans AM; Griffioen AW; Thijssen VL
    PLoS One; 2014; 9(9):e107988. PubMed ID: 25259711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical relevance of galectin-1 expression in non-small cell lung cancer patients.
    Carlini MJ; Roitman P; Nuñez M; Pallotta MG; Boggio G; Smith D; Salatino M; Joffé ED; Rabinovich GA; Puricelli LI
    Lung Cancer; 2014 Apr; 84(1):73-8. PubMed ID: 24560493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients.
    Schulz H; Schmoeckel E; Kuhn C; Hofmann S; Mayr D; Mahner S; Jeschke U
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28594391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-9 in non-small cell lung cancer.
    He Y; Jia K; Dziadziuszko R; Zhao S; Zhang X; Deng J; Wang H; Hirsch FR; Zhou C
    Lung Cancer; 2019 Oct; 136():80-85. PubMed ID: 31454748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression and Clinical Significance of Galcetin-3 in the Serum of Non-small Cell Lung Cancer Patients].
    Qi D; Zhang Y; Li H; Wang R; Qian K
    Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):333-336. PubMed ID: 32429635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of endogenous adhesion/growth-regulatory lectins in lung cancer.
    Szoke T; Kayser K; Baumhakel JD; Trojan I; Furak J; Tiszlavicz L; Horvath A; Szluha K; Gabius HJ; Andre S
    Oncology; 2005; 69(2):167-74. PubMed ID: 16127288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The associations of TERT-CLPTM1L variants and TERT mRNA expression with the prognosis of early stage non-small cell lung cancer.
    Chen Z; Wang J; Bai Y; Wang S; Yin X; Xiang J; Li X; He M; Zhang X; Wu T; Xu P; Guo H
    Cancer Gene Ther; 2017 Jan; 24(1):20-27. PubMed ID: 27982019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prognostic Effect of MAC30 Expression on Patients With Non-Small Cell Lung Cancer Receiving Adjuvant Chemotherapy.
    Ding H; Gui X; Lin X; Chen R; Ma T; Sheng Y; Cai H; Fen Y
    Technol Cancer Res Treat; 2017 Oct; 16(5):645-653. PubMed ID: 27688262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A highly expressed mRNA signature for predicting survival in patients with stage I/II non-small-cell lung cancer after operation.
    Ma N; Si L; Yang M; Li M; He Z
    Sci Rep; 2021 Mar; 11(1):5855. PubMed ID: 33712694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic and predictive value of a malignancy-risk gene signature in early-stage non-small cell lung cancer.
    Chen DT; Hsu YL; Fulp WJ; Coppola D; Haura EB; Yeatman TJ; Cress WD
    J Natl Cancer Inst; 2011 Dec; 103(24):1859-70. PubMed ID: 22157961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets.
    Grosset AA; Labrie M; Vladoiu MC; Yousef EM; Gaboury L; St-Pierre Y
    Oncotarget; 2016 Apr; 7(14):18183-203. PubMed ID: 26933916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the enhancer of zeste homolog 2 in biopsy specimen predicts chemoresistance and survival in advanced non-small cell lung cancer receiving first-line platinum-based chemotherapy.
    Xu C; Hao K; Hu H; Sheng Z; Yan J; Wang Q; Yu L
    Lung Cancer; 2014 Nov; 86(2):268-73. PubMed ID: 25262426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a histology-independent prognostic gene signature for early-stage, non-small-cell lung cancer including stage IA patients.
    Der SD; Sykes J; Pintilie M; Zhu CQ; Strumpf D; Liu N; Jurisica I; Shepherd FA; Tsao MS
    J Thorac Oncol; 2014 Jan; 9(1):59-64. PubMed ID: 24305008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of S100A13 protein is associated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer.
    Miao S; Qiu T; Zhao Y; Wang H; Sun X; Wang Y; Xuan Y; Qin Y; Jiao W
    Thorac Cancer; 2018 Sep; 9(9):1136-1144. PubMed ID: 30047626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic effect of single and multiple cancer-related somatic mutations in resected non-small-cell lung cancer.
    Jao K; Tomasini P; Kamel-Reid S; Korpanty GJ; Mascaux C; Sakashita S; Labbé C; Leighl NB; Liu G; Feld R; Bradbury PA; Hwang DM; Pintilie M; Tsao MS; Shepherd FA
    Lung Cancer; 2018 Sep; 123():22-29. PubMed ID: 30089591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutathione S-transferase PI (GST-PI) mRNA expression and DNA methylation is involved in the pathogenesis and prognosis of NSCLC.
    Grimminger PP; Maus MK; Schneider PM; Metzger R; Hölscher AH; Sugita H; Danenberg PV; Alakus H; Brabender J
    Lung Cancer; 2012 Oct; 78(1):87-91. PubMed ID: 22884253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrin expression profiling identifies integrin alpha5 and beta1 as prognostic factors in early stage non-small cell lung cancer.
    Dingemans AM; van den Boogaart V; Vosse BA; van Suylen RJ; Griffioen AW; Thijssen VL
    Mol Cancer; 2010 Jun; 9():152. PubMed ID: 20565758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05).
    Joerger M; Baty F; Früh M; Droege C; Stahel RA; Betticher DC; von Moos R; Ochsenbein A; Pless M; Gautschi O; Rothschild S; Brauchli P; Klingbiel D; Zappa F; Brutsche M
    Lung Cancer; 2014 Aug; 85(2):306-13. PubMed ID: 24928469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of ERCC1, RRM1, BRCA1 and SETDB1 in early stage of non-small cell lung cancer.
    Lafuente-Sanchis A; Zúñiga Á; Galbis JM; Cremades A; Estors M; Martínez-Hernández NJ; Carretero J
    Clin Transl Oncol; 2016 Aug; 18(8):798-804. PubMed ID: 26542178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of microvascularization and growth/adhesion-regulatory lectins in the prognosis of non-small cell lung cancer in stage II.
    Szöke T; Kayser K; Trojan I; Kayser G; Furak J; Tiszlavicz L; Baumhäkel JD; Gabius HJ
    Eur J Cardiothorac Surg; 2007 May; 31(5):783-7. PubMed ID: 17369045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.